New Data Presented at ISC 2022 Further Validates Impact of the Viz Platform for Intelligent Care Coordination in the Real World
SAN FRANCISCO & NEW ORLEANS–(BUSINESS WIRE)–#AI–Data from several new studies presented this week at the…
Month: February 2022
IAA, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results
Delivers Record 2021 Results Introduces Full-Year 2022 Outlook WESTCHESTER, Ill.–(BUSINESS WIRE)–IAA, Inc. (NYSE: IAA) today…
The Arena Group Announces Pricing of $30,000,000 Public Offering, Following February 9, 2022 Uplisting to the NYSE American
NEW YORK–(BUSINESS WIRE)–The Arena Group Holdings, Inc., formerly known as theMaven, Inc. (NYSEAMERICAN: AREN) (the…
Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2021
Revenue of $123.6 million in the Fourth Quarter of 2021, an increase of 18% year-over-year…
Invitation to Novozymes’ annual shareholders’ meeting 2022
Please read the invitation in PDF Attachment Invitation to Novozymes’ Annual Shareholders’ Meeting 2022
Great News for Job seekers, Recruitment Agencies & Employers: World’s First Blockchain-Certied AI-matched – Trusted NFT Resume Marketplace is here
Tallinn, Estonia–(Newsfile Corp. – February 11, 2022) – TrustRecruit presents the world’s first AI-enabled verified…
New two-year data for Roche’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible…
Nykode Therapeutics announces completion of patient enrollment in its Phase 2 trial of VB10.16 in combination with atezolizumab for the treatment of advanced cervical cancer
Nykode Therapeutics has reached the enrollment target of 50 patients in its VB C-02 trial…
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
Facedrive Provides Update on Facedrive Foods’ Revenue and Expenses
TORONTO–(BUSINESS WIRE)–#FacedriveScarborough–Facedrive Inc. (“Facedrive” or the “Company”) (TSXV:FD), (OTC:FDVRF), a Canadian “people-and-planet first” tech ecosystem…
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
IN8bio to present at Bio CEO & Investor Conference and Next Generation CAR-TCR Summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta…
OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in the Journal of Clinical Microbiology
Publication demonstrates FDA cleared Acuitas AMR Gene Panel detects and differentiates a broad range of…
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Cellectis Appoints Bing Wang, PhD, MBA as Chief Financial Officer
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
VistaGen Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Advancing late-stage PH94B clinical program, including: Progress towards topline data readouts for PALISADE-1 and PALISADE-2…
ObsEva Enters into Licensing Agreement with Theramex for the Commercialization of Linzagolix
– Partnership leverages Theramex’s leading women’s health capabilities and commercial infrastructure to support the commercialization…
FDA Denies Citizen Petitions Filed on Behalf of Short Selling Clients
AUSTIN, Texas, Feb. 10, 2022 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
Telix and SHINE partner for Lutetium-177 Supply
MELBOURNE, Australia and INDIANAPOLIS, Feb. 10, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…